Nicole Drezner

Targeting Cancer Hallmarks with Epigallocatechin Gallate (EGCG): Mechanistic Basis and Therapeutic Targets

Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets

FDA Approval Summary: Sotorasib for KRAS G12C -Mutated Metastatic NSCLC

FDA Approval Summary: Osimertinib for Adjuvant Treatment of Surgically Resected Non–Small Cell Lung Cancer, a Collaborative Project Orbis Review